Clinical Trial Update: Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating inhaled beclomethasone propionate to prevent radiotherapy-induced pneumonia in locally advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Beclomethasone propionate (inhaled) (beclomethasone propionate)

Snippet

Sponsor: Tongji University | Conditions: Locally Advanced Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN